Xenter, Inc. ( Xenter.io announced the recent presentation of its revolutionary dual sensor investigational guidewire for TAVR procedures at the Transcatheter Cardiovascular Therapeutics (TCT) conference 2023 in San Francisco, California. real-time to serve as an aortic regurgitation measurement tool (Xar™) and clinical decision support, thereby significantly improving the prediction of paravalvular leak (PVL) during TAVR.

The guidewire functionality is designed to enable comprehensive data collection and analysis and makes it easier to obtain the data needed for new artificial intelligence (AI) decision-making tools. The goal is to make better-informed clinical decisions and improve patient outcomes. The guidewire is designed to work seamlessly within a proprietary wireless ecosystem in the cardiac catheterization lab, making real-time data and analytics more accessible than ever.

Rich Linder, CEO of Xenter, founded Xenter to revolutionize the collection of Physical Intelligence™ (PI) data into actionable insights. “We designed Xenter to enable artificial intelligence (AI) tools to be used with ease and precision using new smart/wireless medical devices that transmit PI data in real time . Xenter is pioneering “smart” medical devices and a wireless ecosystem that eliminate the capital equipment and mobile carts that clutter hospitals around the world.”

Linder continues: “Xenter launches the XMD™ cloud which interfaces with hospital EMRs and enables the use of AI-driven clinical decision support tools derived from real-time PI data . »

“ The TAVR SmartWire is an excellent example of real-time PI data collection,” said William A. Gray, MD, system chief of cardiovascular medicine at Mainline Healthcare in Philadelphia, Pennsylvania. Dr. Gray continues, “ TAVR SmartWire will provide real-time measurement of aortic and left ventricular pressure information in a single device that can be used to measure aortic regurgitation (AR). We plan to clinically evaluate TAVR SmartWire and provide physicians with a real-time measurement of AR called xAR™.”

Martin B. Leon, MD, chairman emeritus of the Cardiovascular Research Foundation in New York, and professor of medicine at Columbia University/New York Presbyterian Hospital and chair of the global study for TAVR SmartWire said: “From the beginning, we We saw the need to innovate and design new solutions in cardiovascular medicine that can transform the way information is collected during interventional procedures, including TAVR. I look forward to seeing these innovative solutions enter clinical research and demonstrating the clinical utility of xAR™ in transcatheter aortic valve replacement.”

About Xenter

Xenter, Inc. is a privately held company headquartered in Salt Lake City, Utah, focused on developing new wireless medical device technologies that provide real-time Physical Intelligence™ data.

For more information about Xenter, visit Xenter.io .

#InterventionalCardiology #DigitalHealth

The text of the press release resulting from a translation should in no way be considered official. The only authentic version of the press release is that of the press release in its original language. The translation must always be compared with the source text, which will set a precedent.

Contacts
Bryan Osborn:
Bryan.Osborn@Xenter.io
435-773-1345

Mike Russell:
Mike.Russell@Xenter.io
801-554-6080

Source: businesswire.com

Report Abuse